Current position:Home >Product >
(E)-2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)-7-chloroquinoline
(E)-2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)-7-chloroquinoline(1040351-42-5)
- Name: (E)-2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)-7-chloroquinoline
- Synonyms:168214-67-3;1040351-42-5;Montelukast Cyclized Ether impurity;(E)-2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)-7-chloroquinoline;3ZZT672H7X;1,1-dimethyl-2-benzoxepin-3-yl)phenyl]ethenyl]-;(E)-2-(3-(1,1-Dimethyl-1,3,4,5-tetrahydrobenzo-[c]oxepin-3-yl)styryl)-7-chloroquinoline;7-chloro-2-[(E)-2-[3-(1,1-dimethyl-4,5-dihydro-3H-2-benzoxepin-3-yl)phenyl]ethenyl]quinoline;(E)-2-(3-(1,1-Dimethyl-1,3,4,5-tetrahydrobenzo(C)oxepin-3-yl)styryl)-7-chloroquinoline;(E)-7-Chloro-2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)quinoline;Quinoline, 7-chloro-2-((1E)-2-(3-(1,3,4,5-tetrahydro-1,1-dimethyl-2-benzoxepin-3-yl)phenyl)ethenyl)-;Montelukast Cyclizate Ether impurity;UNII-3ZZT672H7X;SCHEMBL1204314;DTXSID50657927;LOMMSDDMLICVMB-XNTDXEJSSA-N;7-Chloro-2-{(E)-2-[3-(1,1-dimethyl-1,3,4,5-tetrahydro-2-benzoxepin-3-yl)phenyl]ethenyl}quinoline
- Molecular Formula:C29H26ClNO
- Molecular Weight:440.0
- CAS Registry Number:1040351-42-5
- EINECS:691-151-7
- Melting Point:
- Water Solubility:
Other Product
- 16808-56-3/9,10-Dihydrospiro[9,10-ethanoanthracene-11,2'-thietane] 1',1'-dioxide
- 914265-99-9/2-[4-(4-fluorophenyl)-2-(hydroxymethyl)-5-oxazolyl]-N-propan-2-yl-4-thiazolecarboxamide
- 1177303-36-4/(4-Methyl-piperidin-1-YL)-acetic acid hydrochloride
- 299921-16-7/4-benzyl-5-(3,4-dimethoxyphenyl)-4H-1,2,4-triazole-3-thiol
- 1788041-56-4/Spiro[cyclopropane-1,3'-indoline] hydrochloride
- 1261912-02-0/4-(5-Chloro-2-methoxyphenyl)-3-methylbenzoic acid
- 258831-76-4/5-Ethoxycarbonyl SU 5402 Methyl Ester
- 4176-47-0/n-(Benzo[c]phenanthren-3-yl)acetamide
- 1209090-23-2/1-Chloro-7-nitro-1,2-dihydropyrrolo[1,2-a]pyrazine
- 2100306-58-7/DBCO-NHCO-PEG4-NHS ester
- 93582-31-1/(Ru(COD)(CF3OCO)2)2
- 1251950-59-0/1,3-Diethyl 2-(4-fluoro-5-methyl-2-nitrophenyl)-propanedioate
- 898760-71-9/3-(3-Bromophenyl)-1-(2,5-dichlorophenyl)propan-1-one
- 1072944-31-0/(4'-(Pentan-3-yloxy)-[1,1'-biphenyl]-4-yl)boronic acid
- 127451-12-1/2-Methyl-3-(prop-1-en-2-yl)benzaldehyde
- 396091-76-2/Pasireotide acetate
- 1174064-66-4/2-(4-bromo-1H-pyrazol-1-yl)benzaldehyde
- 1889287-68-6/(S)-1,1,1-trifluoro-N-(4-fluorobenzyl)propan-2-amine
- 1227056-84-9/Ampreloxetine
- 1040351-42-5/(E)-2-(3-(1,1-dimethyl-1,3,4,5-tetrahydrobenzo[c]oxepin-3-yl)styryl)-7-chloroquinoline
- 304668-18-6/2,2,2-trifluoro-N-[4-(trifluoromethoxy)phenyl]acetamide
- 288151-45-1/7,8-Difluoro-2-methylquinolin-4-ol
- 1220019-71-5/4-[2-(2,3-Dimethylphenoxy)ethyl]piperidine hydrochloride
- 898777-10-1/Ethyl 5-oxo-5-[(4-pyrrolidinomthyl)phenyl]valerate
- 1299607-47-8/1-(7-Bromo-6-(3-((tert-butyldimethylsilyl)oxy)propyl)-2,3-dihydro-1h-pyrido[2,3-b][1,4]oxazin-1-yl)-2,2-dimethylpropan-1-one
- 1196154-73-0/Methyl 2-(4-aminophenyl)-2-bromoacetate
- 2225824-53-1/CID 134477586
- 1346447-34-4/tert-Butyl (3-iodo-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)carbamate
- 946714-44-9/3-(4-Bromophenoxy)piperidine
- 1052075-57-6/7,7,9,9,11,11,13,13,15,15-Decamethyl-3,8,10,12,14-pentaoxa-7,9,11,13,15-pentasilanonadecan-1-yl 2-methylprop-2-enoate